Testosterone nasal gel (Natesto) for hypogonadism.
In one study, Natesto nasal gel administered intranasally 3 times daily was effective in raising low serum testosterone levels into the normal range in patients with hypogonadism. Whether patients will find this method of administration more acceptable than an intramuscular injection every 2-4 weeks or once-daily application to the skin remains to be determined. Based on the lack of convincing evidence of benefit in older men and concerns about its safety, the FDA has warned against using testosterone to treat hypogonadism due solely to aging.
D000279:Administration, Cutaneous; D000281:Administration, Intranasal; D000818:Animals; D002986:Clinical Trials as Topic / Q000379:methods; D005782:Gels; D006801:Humans; D007006:Hypogonadism / Q000175:diagnosis / Q000188:drug therapy*; D008297:Male; D013739:Testosterone / Q000008:administration & dosage* / Q000737:chemistry
D005782:Gels; D013739:Testosterone